Sponsor pipeline

Ottimo Pharma Limited clinical trial pipeline

Get alerts when Ottimo Pharma Limited's trials change

1 active trials 1 recruiting 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07266428 A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid… Advanced Solid Tumors Recruiting 2026-10-09
Get alerts when Ottimo Pharma Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free